Brief: Kazia Therapeutics Posts Loss For Half-Year Attributable Of A$13.0 Million
23/02/2022 06:14
Feb 23 (Reuters) - Kazia Therapeutics Ltd KZA.AX :
* LOSS FOR HALF-YEAR ATTRIBUTABLE A$13.0 MILLION
Source text for Eikon: ID:nASX1QlZJN
Further company coverage: KZA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kazia Therapeutics
See all newsBrief: Kazia Therapeutics Files For Mixed Shelf Of Up To $100 Million – SEC Filing
Brief: Kazia Announces Voluntary Delisting From ASX
Australia's Kazia Therapeutics slumps to 1-yr low on delisting announcement
Brief: Kazia Therapeutics Announces Intention To Voluntarily De-List From ASX
Brief: Kazia Therapeutics Seeks Trading Halt